EZH2 and prostate neoplasm: In summary, the present study demonstrates that miR-141, devoid in PCSCs, suppresses prostate tumour growth and metastasis by targeting a cohort of prometastasis genes including CD44, EZH2 and Rho GTPases (Fig. 6j).